These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1837032)

  • 1. Bactericidal activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae and streptococcal pathogens.
    Gu JW; Scully BE; Neu HC
    J Clin Pharmacol; 1991 Dec; 31(12):1146-50. PubMed ID: 1837032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activity of clarithromycin and its 14-hydroxy metabolite against Haemophilus influenzae, determined by in-vitro and serum bactericidal tests.
    Dabernat H; Delmas C; Seguy M; Fourtillan JB; Girault J; Lareng MB
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():19-30. PubMed ID: 1827099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative in vitro activity of A-56268 against respiratory tract pathogens.
    Jansson L; Kalin M
    Eur J Clin Microbiol; 1987 Aug; 6(4):494-6. PubMed ID: 2959474
    [No Abstract]   [Full Text] [Related]  

  • 4. Individual and combined activities of clarithromycin and its 14-hydroxy metabolite in a murine model of Haemophilus influenzae infection.
    Vallée E; Azoulay-Dupuis E; Swanson R; Bergogne-Bérézin E; Pocidalo JJ
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():31-41. PubMed ID: 1827100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin.
    Hoover WW; Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1992; 15(3):259-66. PubMed ID: 1533827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of clarithromycin and its 14-hydroxy-metabolite against 203 strains of Haemophilus influenzae.
    Bergeron MG; Bernier M; L'Ecuyer J
    Infection; 1992; 20(3):164-7. PubMed ID: 1386590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro activity of clarithromycin combined with its 14-hydroxy metabolite A-62671 against Haemophilus influenzae.
    Olsson-Liljequist B; Hoffman BM
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():11-7. PubMed ID: 1827097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bactericidal activity of moxifloxacin compared to grepafloxacin and clarithromycin against Streptococcus pneumoniae and Streptococcus pyogenes investigated using an in vitro pharmacodynamic model.
    Esposito S; Noviello S; Ianniello F
    J Chemother; 2000 Dec; 12(6):475-81. PubMed ID: 11154028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro comparative dynamics of modified-release clarithromycin and of azithromycin.
    Scaglione F; Demartini G; Dugnani S; Fraschini F
    Chemotherapy; 2000; 46(5):342-52. PubMed ID: 10965100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial activity of the new macrolide flurithromycin against Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes, Branhamella catarrhalis and Staphylococcus aureus.
    Nord CE; Lindmark A; Persson I
    J Chemother; 1989 Jul; 1(4 Suppl):203-4. PubMed ID: 16312369
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma bactericidal activity after administration of erythromycin estolate and erythromycin ethylsuccinate to healthy volunteers.
    Bérubé D; Kirouac D; Croteau D; Bergeron MG; Lebel M
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1227-30. PubMed ID: 3142349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antimicrobial susceptibility of Streptococcus pyogenes, Haemophilus influenzae, Streptococcus pneumoniae and Moraxella catarrhalis from community acquired respiratory infections in 2000].
    Melo-Cristino J; Fernandes ML; Serrano N;
    Acta Med Port; 2001; 14(5-6):459-68. PubMed ID: 11878155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
    Dan M; Poch F; Edelman A; Asherov J; Hafely H; Atzmon Y
    J Antimicrob Chemother; 1998 Apr; 41(4):485-8. PubMed ID: 9598780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans.
    Hardy DJ; Swanson RN; Rode RA; Marsh K; Shipkowitz NL; Clement JJ
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1407-13. PubMed ID: 2143642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro bactericidal activity of ABT-773 versus four other agents against Streptococcus pneumoniae and Haemophilus influenzae.
    Neuhauser MM; Jung R; Danziger LH; Pendland SL
    Int J Antimicrob Agents; 2002 Nov; 20(5):395-8. PubMed ID: 12431879
    [No Abstract]   [Full Text] [Related]  

  • 16. Multicenter surveillance of antimicrobial resistance of Streptococcus pyogenes, Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis to 14 oral antibiotics.
    Hsueh PR; Huang WK; Shyr JM; Lau YJ; Liu YC; Luh KT
    J Formos Med Assoc; 2004 Sep; 103(9):664-70. PubMed ID: 15361938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetic bactericidal activity of telithromycin, azithromycin and clarithromycin against respiratory pathogens.
    Drago L; De Vecchi E; Nicola L; Legnani D; Gismondo MR
    APMIS; 2005 Oct; 113(10):655-63. PubMed ID: 16309423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of clarithromycin and its principal human metabolite against Haemophilus influenzae.
    Jorgensen JH; Maher LA; Howell AW
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1524-6. PubMed ID: 1834012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.
    Blandino G; Aleo G; Caccamo F; Nicolosi VM; Siracusa V; Speciale A
    J Chemother; 1996 Jun; 8(3):193-9. PubMed ID: 8808715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibiotic sensitivity of Haemophilus influenzae, Streptococcus pneumoniae, Streptococcus pyogenes and Branhamella catarrhalis isolated from upper respiratory tract infections in Sweden.
    Kallings I; Bengtsson S; Christensen P; Holm SE; Lind L; Kalin M
    Scand J Infect Dis Suppl; 1983; 39():100-5. PubMed ID: 6359377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.